Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel
Authors:
- Selcuk DasdemirSDSelcuk Dasdemir
- Mehmet YildizMYMehmet Yildiz
- Damla CelebiDCDamla Celebi
- Sezgin SahinSSSezgin Sahin
- Numune AliyevaNANumune Aliyeva
- Fatih HaslakFHFatih Haslak
- Aybuke GunalpAGAybuke Gunalp
- Amra AdrovicAAAmra Adrovic
- Kenan BarutKBKenan Barut
- Bahar Artim EsenBEBahar Artim Esen
- Ozgur KasapcopurOKOzgur Kasapcopur
- 27 January 2022
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 31 (3) , 330-337
Abstract
Objective: In this study, we aimed to screen 31 genes (C1QA, C1QB, C1QC, C1R, C1S, C2, C3, TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, DNASE1, DNASE1L3, PRKCD, ACP5, SLC7A7, IFIH1, TMEM173, ISG15, CYBB, FAS, FASLG, KRAS, NRAS, MAN2B1, PEPD, PTPN11, RAG2, and SHOC2), that we have categorized under the umbrella term “monogenic lupus” using a targeted next-generation sequencing (NGS) panel in 24 individuals with early-onset (≤10 years of age) systemic lupus erythematosus (SLE) and in 24 patients with late-onset (>10 years of age) disease. Methods: A total of 48 SLE patients (24 with disease onset ≤10 years of age and 24 with disease onset >10 years of age) were included. Patients with late-onset disease have been used as patient controls. Sequencing was carried out using 400 bp kit on the Ion S5 system. Results: Among the 48 patients, three had one pathogenic variant and 45 patients had at least one rare variant classified as benign, likely benign or variant of unknown significance (VUS). In all three patients with a pathogenic variant, the onset of disease was before 10 years of age. Two patients (they were siblings) carried C1QA homozygote pathogenic allele (p.Gln208Ter, rs121909581), and one patient carried PEPD heterozygote pathogenic allele (p.Arg184Gln, rs121917722). Conclusion: We demonstrated a pathogenic variant in our target gene panel with a frequency of 9.52% in patients with a disease onset ≤10 years of age. All patients with early-onset SLE phenotype, irrespective of a positive family history for SLE or parental consanguinity, should be scanned for a single-gene defect by a targeted gene panel sequencing. With the discovery of many single-gene defects and ongoing efforts to identify novel genes in SLE, similar gene panels including even more genes will possibly become more necessary and practical in the future.Keywords
Funding Information
- Istanbul University Scientific Research Fund (TSA-2019-34472)
This publication has 28 references indexed in Scilit:
- Complement C2 deficiency disarranging innate and adaptive humoral immune responses in a pediatric patient: Treatment with rituximabArthritis Care & Research, 2011
- Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patientsAnnals of the Rheumatic Diseases, 2011
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- The non-classical functions of the classical complement pathway recognition subcomponent C1qImmunology Letters, 2010
- Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosusNature Genetics, 2008
- Clinical variability and characteristic autoantibody profile in primary C1q complement deficiencyRheumatology, 2007
- Complement deficiencies and systemic lupus erythematosusAutoimmunity, 2007
- Hereditary C1q deficiency and secondary Sjögren's syndromeAnnals of the Rheumatic Diseases, 2004
- Direct binding of C1q to apoptotic cells and cell blebs induces complement activationEuropean Journal of Immunology, 2002
- Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish familyKidney International, 1996